Not Tagged
Not Tagged
['nsclc', 'sclc']
having the myriad of options in ret driven tumors is just great. kl590586, a highly selective ret inhibitor, shows a good safety profile, with no dlts. consistent signs of clinical efficacy with previous drugs. amazing efficacy in nsclc. will it be better than the soc? #asco23 
Husband, Father. Medical Oncologist and Researcher focused in Thoracic Oncology.  Views are my own. Member of @latenightonc - the best podcast in oncology!